Chemed Inventory Turnover Ratio 2010-2023 | CHE

Current and historical inventory turnover ratio for Chemed (CHE) from 2010 to 2023. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Chemed inventory turnover ratio for the three months ending December 31, 2023 was 29.85.
Chemed Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.473B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.978B 10.27
Quest Diagnostics (DGX) United States $15.146B 15.65
DaVita (DVA) United States $12.474B 15.49
Encompass Health (EHC) United States $8.354B 21.50
Elanco Animal Health (ELAN) United States $6.655B 15.14
Option Care Health (OPCH) United States $5.195B 19.66
RadNet (RDNT) United States $3.817B 103.32
Amedisys (AMED) United States $3.020B 21.40
LifeStance Health (LFST) United States $2.496B 0.00
Astrana Health (ASTH) United States $2.077B 25.92
Addus HomeCare (ADUS) United States $1.611B 24.48
U.S Physical Therapy (USPH) United States $1.562B 40.48
Pennant (PNTG) United States $0.636B 37.19
Aveanna Healthcare Holdings (AVAH) United States $0.437B 0.00
Atai Life Sciences (ATAI) Germany $0.357B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
ATI Physical Therapy (ATIP) United States $0.019B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00